Sai Parenterals Maiden Public Issue

Key Details:

• Issue Size: Rs 409 crore
• Price Band: Rs 372-392 per share
• Valuation: Rs 1,732 crore
• IPO Dates:

• Anchor book launch: March 23
• Public issue open: March 24 - March 27
• Share allotment finalisation: March 30
• Listing: April 2

Issue Breakdown:

Read also: SpaceX Seeks Record $75 Billion IPO, Potentially Positioning Elon Musk as the World's First Trillionaire

• Fresh Issue: up to Rs 285 crore
• Offer-for-Sale: 31.57 lakh shares by investors including Vikasa India EIF I Fund, Tilokchand Punamchand Ostwal, Devendra Chawla, Ashish Maheshwari, Padma Guntupalli, Bhautik Mukund Shah, and Nilesh Pravinchandra Doshi

Company Profile:

• Sai Parenterals is a pharmaceutical company that provides branded generic formulations and CDMO (contract development and manufacturing organisation) products and services through its five manufacturing facilities in Telangana and Andhra Pradesh.

Proceeds Allocation:

Read also: SMR Jewels IPO Successfully Lists with Institutional Support

• Capacity Expansion: Rs 110.7 crore
• R&D Centre Establishment: Rs 18 crore
• Borrowing Repayment: Rs 50 crore
• Working Capital: Rs 33 crore
• General Corporate Purposes: balance funds

Financial Performance:

• Six Months Ended September 2025:

• Revenue: Rs 86.9 crore
• Profit: Rs 7.7 crore

• Financial Year Ended March 2025:

• Revenue: Rs 163.1 crore (6% growth from previous year)
• Profit: Rs 14.4 crore (71.8% growth from previous year)

Merchant Banker: Arihant Capital Markets is the sole merchant banker managing the Sai Parenterals IPO.